Pharmaceutical companies in the U.S. spend twice as much money promoting their products as they do on R&D. Such was the conclusion reached by Marc-André Gagnon, lecturer in the departments of Economics and Sociology and main author of an article published today in the scientific journal PLoS Medicine. The paper, which was co-authored with Joel Lexchin of York University, presented the results of a study designed to systematically calculate the total amounts of money devoted to the promotion of pharmaceutical products.
The Cost of Pushing Pills : A New Estimate of Pharmaceutical
Promotion Expenditures in the United States